Crossref
106 Drug Optimization for Eczema Treatment
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103161
DOI: 10.1016/j.japh.2026.103161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von M. Diep und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Diep, M., On, T., & Totonchy, J. (2026). 106 Drug Optimization for Eczema Treatment. Journal of the American Pharmacists Association, 66(4), 103161. https://doi.org/10.1016/j.japh.2026.103161
Vancouver
Diep M, On T, Totonchy J. 106 Drug Optimization for Eczema Treatment. Journal of the American Pharmacists Association. 2026;66(4):103161. doi:10.1016/j.japh.2026.103161
BibTeX
@article{Diep2026,
author = {Diep, M. and On, T.J. and Totonchy, J.},
title = {106 Drug Optimization for Eczema Treatment},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103161},
doi = {10.1016/j.japh.2026.103161}
}
EUVIMED